Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-23,400
Closed -$4.98M 10951
2025
Q3
$4.98M Buy
23,400
+14,300
+157% +$2.62M ﹤0.01% 4037
2025
Q2
$1.55M Buy
+9,100
New +$1.31M ﹤0.01% 5063
2022
Q1
Sell
-500
Closed -$46K 10666
2021
Q4
$46K Hold
500
﹤0.01% 6986
2021
Q3
$43K Hold
500
﹤0.01% 6464
2021
Q2
$53K Sell
500
-200
-29% -$21.7K ﹤0.01% 6378
2021
Q1
$66K Buy
700
+400
+133% +$34.2K ﹤0.01% 6282
2020
Q4
$20K Buy
+300
New +$16.8K ﹤0.01% 6946

Other funds holding MTZ

UBS Group's MTZ Position: Q1 2026 in Review

UBS Group reduced its MasTec (MTZ) stake by 15% in Q1 2026, selling an estimated $18.9M and leaving 381,115 shares worth $123M. The position accounts for 0.02% of the portfolio, ranked #900.

UBS Group first reported a position in MTZ in Q4 2014 and has held it in 46 quarters since. 806 funds tracked by Wall St. Rank hold MTZ as of Q1 2026.

  • UBS Group held 381,115 shares of MasTec worth $123M as of Q1 2026.
  • UBS Group sold 69,888 MasTec shares in Q1 2026, an estimated $18.9M.
  • MasTec made up 0.02% of UBS Group's portfolio in Q1 2026, its #900 holding.
  • UBS Group first reported a position in MasTec in Q4 2014 and has held it in 46 quarters since.
  • 806 funds tracked by Wall St. Rank held MasTec as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.